Scholars Central

Research articlePublished 2014

Production of Good Manufacturing Practice Grade Equine Adiposederived Mesenchymal Stem Cells for Therapeutic Use

Authors: Shashank Gowda, Aarya Hari, Basavaraj Chougule, Manoj Kumar Reddy, Abhishek Chandanan, Minita Sodhi, Nicole Koshy, Lyle Fonseca, Satish Totey

Journal of Stem Cell Research & Therapy

Volume 4 · Issue 1 · Pages 1–11

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Mesenchymal stem cells (MSC) are currently being evaluated in equine clinical studies for their potential to treat various disorders and injuries. Studies have shown that both autologous and allogeneic stem cells appear to be safe. However, an efficient cell expansion method that is reliable and cost-effective is warranted to provide off-the-shelf clinical grade stem cells. Our study aimed to determine optimum culture conditions for efficient large-scale stem cell expansion. We produced cGMP standard equine adipose derived mesenchymal stem cells on a large scale. Five different medium combinations—Dulbecco’s modified Eagle’s medium-knockout (DMEM-KO), alpha modified minimum essential medium (α-MEM), 50:50 DMEM-KO/α-MEM, 75:25 DMEM-KO/α-MEM and 25:75 DMEM-KO/α- MEM—at seeding densities of 1000, 2000, 3000, 4000 and 5000 cells/cm2, were used to determine the optimum culture conditions for large-scale production. Growth kinetics, immunophenotypes, karyotypes, morphology, trilineage differentiation, T-cell proliferation, virus positivity, pre-clinical toxicity and expression of pluripotency markers were analysed. Among the medium combinations and seeding densities tested, 25:75 DMEM-KO/α-MEM at a seeding density of 5000 cells/cm2 was found to be optimum for large-scale expansion. This medium combination gave a significantly higher cell yield than the other medium combinations, while preserving their stem cell characteristics and differentiation potential. The results indicated that the adoption of an appropriate culture system significantly improved cell yield, thus enabling the production of sufficient cells for therapeutic application in a cost-effective manner. The results also showed that the method of large-scale expansion requires minimal manipulation of cells, and it could be expanded ex vivo within two passages while retaining the characteristics of true stem cells.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Shashank Gowda”
  • BylineArticles whose byline prints “Aarya Hari”
  • BylineArticles whose byline prints “Basavaraj Chougule”
  • BylineArticles whose byline prints “Manoj Kumar Reddy”
  • BylineArticles whose byline prints “Abhishek Chandanan”
  • BylineArticles whose byline prints “Minita Sodhi”
  • BylineArticles whose byline prints “Nicole Koshy”
  • BylineArticles whose byline prints “Lyle Fonseca”